View Archive »
About The Cover
The cover for issue 69 of Oncotarget features Figure 5, "qRT-PCR analysis of select mRNAs in mTORC1/2 inhibited cells with and without carboplatin treatment," by David-West, et al.
|
|
Table of Contents
News
|
| CpG island hypermethylation go circular RNA |
|
https://doi.org/10.18632/oncotarget.26074
|
| 33052-33053 |
Editorial
|
| Checks and balances occur not only in government but also in biology |
|
https://doi.org/10.18632/oncotarget.25876
|
| 33054-33055 |
|
| MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25887
|
| 33056-33058 |
|
| 177LutetiumDotatate delays decline in quality of life in patients with midgut neuroendocrine tumors |
|
https://doi.org/10.18632/oncotarget.25942
|
| 33059-33059 |
|
| Prognostic markers for colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26012
|
| 33060-33061 |
|
| Population based germline testing for primary cancer prevention |
|
https://doi.org/10.18632/oncotarget.25995
|
| 33062-33063 |
Priority Research Papers
|
| mTORC1/2 inhibition resensitizes platinumresistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs |
|
https://doi.org/10.18632/oncotarget.25869
|
| 33064-33076 |
Research Papers
|
| Distinct urinary glycoprotein signatures in prostate cancer patients |
|
https://doi.org/10.18632/oncotarget.26005
|
| 33077-33097 |
|
| Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.26006
|
| 33098-33109 |
|
| The Jumonjidomain histone demethylase inhibitor JIB04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma resulting in impaired cell proliferation and survival and reduced tumor growth |
|
https://doi.org/10.18632/oncotarget.26011
|
| 33110-33123 |
|
| Fludarabineresistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.26043
|
| 33124-33137 |
|
| Trisenox disrupts MDM2DAXXHAUSP complex and activates p53 cell cycle regulation and apoptosis in acute leukemia cells |
|
https://doi.org/10.18632/oncotarget.26025
|
| 33138-33148 |
|
| Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia |
|
https://doi.org/10.18632/oncotarget.26032
|
| 33149-33159 |
|
| Prediction of nonmuscleinvasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8+ T cells |
|
https://doi.org/10.18632/oncotarget.26036
|
| 33160-33169 |
|
| Autotaxinβ interaction with the cell surface via syndecan4 impacts on cancer cell proliferation and metastasis |
|
https://doi.org/10.18632/oncotarget.26039
|
| 33170-33185 |
|
| miR665 targets cMYC and HDAC8 to inhibit murine neuroblastoma cell growth |
|
https://doi.org/10.18632/oncotarget.26046
|
| 33186-33201 |
|
| Biochemical and cellular consequences of the antithrombin pMet1 mutation identified in a severe thrombophilic family |
|
https://doi.org/10.18632/oncotarget.26059
|
| 33202-33214 |
|
| Hematopoietic stem cell specific VATPase controls breast cancer progression and metastasis via cytotoxic T cells |
|
https://doi.org/10.18632/oncotarget.26061
|
| 33215-33231 |
|
| Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic |
|
https://doi.org/10.18632/oncotarget.26075
|
| 33232-33243 |
Corrections
|
| Correction: Antibody targeting TSPAN12/βcatenin signaling in vasoproliferative retinopathy |
|
https://doi.org/10.18632/oncotarget.26102
|
| 33244-33244 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
